cyclohexane-1-carboxamide;Cyclohexanecarboxamide, N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]-, (1R,3S)-;GSK-2256294,GSK-2256294A,GSK2256294A,Inhibitor,Epoxide Hydrolase,GSK2256294,inhibit,cigarette smoke-exposure model,oral,COPD,...
关键字: GSK-2256294A | Inhibitor | Epoxide Hydrolase | inhibit | cigarette smoke-exposure model | GSK2256294 | oral | COPD | cardiovascular | inflammation | GSK2256294A | GSK-2256294相关产品: beta-Amyrin acetate | AUDA | Dual FAAH/sEH-IN-1 | CUDA | trans-AUCB | sEH inhibitor-16 | ...
clinical trialCOPDsmokingsoluble epoxide hydrolaseAIMSLazaar, Aili L.Yang, LucyBoardley, Rebecca L.Goyal, Navin S.Robertson, JonathanBaldwin, Sandra J.Newby, David E.Wilkinson, Ian B.Tal-Singer, RuthMayer, Ruth J.Cheriyan, JosephBritish Journal of Clinical Pharmacology...
(1R,3S)-;GSK-2256294,GSK-2256294A,GSK2256294A,Inhibitor,Epoxide Hydrolase,GSK2256294,inhibit,cigarette smoke-exposure model,oral,COPD,cardiovascular,inflammation;(1R,3S)-N-(4-Cyano-2-(trifluoromethyl)benzyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexane-1-carboxamide;GSK...